Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
Study includes an interim short-term, open label period. Patients could also receive a second course of open label treatment dependent on disease exacerbation.
Age
2–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must have Atopic Dermatitis
Patient must be at least 2 years of age
You may not be if
Patient is pregnant or breast feeding an infant
Clareo Health | A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
